𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives

✍ Scribed by A-Yong Cao; Juan Huang; Zhen Hu; Wen-Feng Li; Zhong-Liang Ma; Li-Li Tang; Bin Zhang; Feng-Xi Su; Jie Zhou; Gen-Hong Di; Kun-Wei Shen; Jiong Wu; Jin-Song Lu; Jian-Min Luo; Wen-Tao Yuan; Zhen-Zhou Shen; Wei Huang; Zhi-Ming Shao


Publisher
Springer US
Year
2008
Tongue
English
Weight
189 KB
Volume
115
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The analysis of BRCA1 mutations in easte
✍ Zhen Hu; Jiong Wu; Can-Hui Liu; Jing-Song Lu; Jian-Ming Luo; Qi-Xia Han; Zhen-Zh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 2 views

To study the BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives, 41 patients' genomic DNA from peripheral mononuclear blood cells was studied by using single strand conformational polymorphism (SSCP) and DNA sequencing. The BRCA1 mutations were detected

Mutational analysis of the BRCA1-interac
✍ Joni L. Rutter; Amelia M. Smith; Michael R. DΓ‘vila; Alice J. Sigurdson; Ruthann πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 1 views

Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially inherited breast/ovarian cancer, all of which wer

BRCA1 and BRCA2 mutations in women with
✍ Lenka Foretova; Eva Machackova; Marie Navratilova; Hana Pavlu; Marcela Hruba; Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 45 KB πŸ‘ 2 views

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu